Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin versus orlistat on cardiovascular and metabolic profile in obese children
PACTR202606518409008Phase 4Not yet recruiting
- Sponsor
- Faculty of Medicine, Tanta University
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of metformin and orlistat in obesity, sponsored by Faculty of Medicine, Tanta University. Primary endpoint: Change in body mass index. Planned start May 2026; status: not yet recruiting.
02
Drugs
metforminorlistat
03
Conditions
obesity
Beyond the preview
Go deeper on PACTR202606518409008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202606518409008.